1ACHC Stock Chart & Stats
€23.40
--
Market closed
€23.40
--
Day’s Range― - ―
52-Week Range€6.00 - €46.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)36.00
Market Cap
€2.79B
Enterprise Value€4.85K
Total Cash (Recent Filing)€158.47M
Total Debt (Recent Filing)€2.67B
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Jul 28, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.24
Shares Outstanding91,967,026
10 Day Avg. Volume0
30 Day Avg. Volume36
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.39
P/FCF Ratio-2.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€28.27Price Target Upside20.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)1.32
Revenue Forecast (FY)€2.99B
Bulls Say, Bears Say
Bulls Say
Same‑facility Revenue GrowthSustained same‑facility revenue growth and higher revenue per patient day signal durable demand for behavioral health services. This reflects stronger utilization and pricing power across core facilities, supporting predictable mid‑term top‑line expansion as new beds and ramps continue.
Improving Adjusted EBITDA And Raised GuidanceRising adjusted EBITDA and a raised full‑year target point to better operating leverage from cost efficiencies and tighter corporate controls. Persistent margin improvement suggests management execution that can sustainably convert revenue gains into higher operating profitability over the next several quarters.
Capacity Expansion And Strategic JVsRapid bed additions and joint‑venture partnerships expand capacity and referral networks, creating scalable, asset‑light growth pathways. JVs with established health systems diversify payor/referral sources and improve market access, supporting sustained revenue growth as ramps mature.
Bears Say
Sharp Profitability DeteriorationA large recent net loss and negative margins represent a material hit to earnings quality. Even with revenue gains, sustained profitability erosion undermines retained earnings, limits reinvestment capacity, and raises the bar for management to restore durable net income over the medium term.
Meaningfully Higher LeverageElevated leverage and reported net leverage near 3.9x–4.5x constrain balance‑sheet flexibility, increase interest exposure, and raise refinancing risk if cash flow weakens. Higher leverage limits strategic optionality and makes the company more sensitive to reimbursement or operational setbacks.
Payer Denials And Supplemental Payment UncertaintyBroad‑based payer denials and rising bad debt impair cash collection and increase revenue volatility. Reliance on regulatory supplemental payments that remain uncertain creates earnings upside contingent on approvals, but also structural reimbursement risk that can persistently pressure margins and cash flow.
Acadia Healthcare News
1ACHC FAQ
What was Acadia Healthcare Company, Inc.’s price range in the past 12 months?
Acadia Healthcare Company, Inc. lowest stock price was €6.00 and its highest was €46.00 in the past 12 months.
What is Acadia Healthcare Company, Inc.’s market cap?
Acadia Healthcare Company, Inc.’s market cap is €2.79B.
When is Acadia Healthcare Company, Inc.’s upcoming earnings report date?
Acadia Healthcare Company, Inc.’s upcoming earnings report date is Jul 28, 2026 which is in 2 days.
How were Acadia Healthcare Company, Inc.’s earnings last quarter?
Acadia Healthcare Company, Inc. released its earnings results on Apr 29, 2026. The company reported €0.325 earnings per share for the quarter, beating the consensus estimate of €0.233 by €0.092.
Is Acadia Healthcare Company, Inc. overvalued?
According to Wall Street analysts Acadia Healthcare Company, Inc.’s price is currently Undervalued.
Does Acadia Healthcare Company, Inc. pay dividends?
Acadia Healthcare Company, Inc. does not currently pay dividends.
What is Acadia Healthcare Company, Inc.’s EPS estimate?
Acadia Healthcare Company, Inc.’s EPS estimate is 0.3.
How many shares outstanding does Acadia Healthcare Company, Inc. have?
Acadia Healthcare Company, Inc. has 91,967,026 shares outstanding.
What happened to Acadia Healthcare Company, Inc.’s price movement after its last earnings report?
Acadia Healthcare Company, Inc. reported an EPS of €0.325 in its last earnings report, beating expectations of €0.233. Following the earnings report the stock price went down -17.5%.
Which hedge fund is a major shareholder of Acadia Healthcare Company, Inc.?
Currently, no hedge funds are holding shares in IT:1ACHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Acadia Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€28.27 (20.79% Upside)
€28.27 (20.79% Upside)
Blogger Sentiment
Bullish
IT:1ACHC Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.06%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-9.78%
Trailing 12-Months
Company Description
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
1ACHC Stock 12 Month Forecast
Average Price Target
€28.27
▲(20.79% Upside)